Sign In
Buy RXST
$5.06
+0.110 (+2.22%)
At Close: Jul 13, 2026
RxSight, Inc. Expands Commercial Leadership with Addition of Steve Everly as Vice-President of U.S. Sales
04:05pm, Tuesday, 17'th Aug 2021
ALISO VIEJO, Calif., Aug. 17, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company, today announced that Steve Everly has joined the company as its Vice Pres
RXST Stock Price Increased 11.45%: Why It Happened
05:29pm, Wednesday, 11'th Aug 2021
The stock price of RxSight Inc (NASDAQ: RXST) increased 11.45%. This is why it happened.
RxSight Announces Appointments to its Board of Directors
08:05pm, Tuesday, 10'th Aug 2021
ALISO VIEJO, Calif., Aug. 10, 2021 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company, today announced the appointment of three new members to its Board of Directors effective as
